Join colleagues from across the state at 12:00pm ET (11:00am CT) on Tuesday, December 10 for a free webinar led by Jennifer Schoch, MD, FAAD, clinical professor at the University of Florida Department of Dermatology.
Atopic dermatitis (AD) is a chronic disease with a heavy burden on patients and families. Traditional topical treatments have limits in efficacy and safety, but new biologics for pediatric and adult patients are transforming the AD treatment landscape. Challenges remain in assessing AD severity, particularly with age- and race-related differences, and in using targeted therapies effectively in children. This program offers expert guidance on evaluating AD in children and strategies for integrating biologic therapy.
After attending the webinar, you will be able to:
- Diagnose AD and evaluate disease severity in children, taking into consideration age- and race-related features
- Collaborate with other specialists in the management of pediatric patients with AD and as children transition to adult care
- Summarize the rationale and recent clinical evidence for the use of targeted therapy in appropriate pediatric patients with AD
- Develop treatment plans for pediatric patients with AD, including the use of targeted therapy, according to the latest clinical evidence
The webinar, Clearing the Way for Pediatric Patients of All Races with Moderate to Severe Atopic Dermatitis: Expert Perspectives on Identifying and Assessing Disease Severity and Implementing Targeted Treatment, is free to attend and provides 1 AMA PRA Category 1 CreditTM, 1 MOC points in the American Board of Pediatrics’ Maintenance of Certification program, and AAPA Category 1 CME credits. Register for free here.
